Labcorp EBITDA Margin 2010-2024 | LH

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Labcorp (LH) over the last 10 years. The current EBITDA margin for Labcorp as of March 31, 2024 is .
Labcorp EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $12.30B $1.31B 10.63%
2023-12-31 $12.16B $1.30B 10.71%
2023-09-30 $11.30B $1.36B 11.99%
2023-06-30 $11.11B $1.47B 13.22%
2023-03-31 $11.00B $1.60B 14.50%
2022-12-31 $11.87B $1.97B 16.64%
2022-09-30 $10.76B $2.44B 22.66%
2022-06-30 $11.96B $2.88B 24.12%
2022-03-31 $12.88B $3.24B 25.13%
2021-12-31 $13.14B $3.63B 27.60%
2021-09-30 $16.56B $4.56B 27.57%
2021-06-30 $16.39B $5.27B 32.16%
2021-03-31 $15.32B $4.82B 31.48%
2020-12-31 $13.98B $3.53B 25.27%
2020-09-30 $12.44B $2.55B 20.46%
2020-06-30 $11.48B $1.37B 11.94%
2020-03-31 $11.59B $1.41B 12.12%
2019-12-31 $11.56B $1.91B 16.50%
2019-09-30 $11.39B $1.86B 16.33%
2019-06-30 $11.29B $1.85B 16.40%
2019-03-31 $11.28B $1.88B 16.70%
2018-12-31 $11.33B $1.88B 16.56%
2018-09-30 $11.29B $1.91B 16.89%
2018-06-30 $11.08B $1.89B 17.07%
2018-03-31 $10.74B $1.84B 17.13%
2017-12-31 $10.31B $1.84B 17.83%
2017-09-30 $9.90B $1.78B 17.92%
2017-06-30 $9.70B $1.76B 18.16%
2017-03-31 $9.60B $1.79B 18.69%
2016-12-31 $9.55B $1.77B 18.53%
2016-09-30 $9.52B $1.71B 17.97%
2016-06-30 $9.42B $1.69B 17.98%
2016-03-31 $9.26B $1.64B 17.75%
2015-12-31 $8.68B $1.46B 16.77%
2015-09-30 $7.89B $1.38B 17.50%
2015-06-30 $7.13B $1.25B 17.57%
2015-03-31 $6.37B $1.12B 17.60%
2014-12-31 $6.01B $1.15B 19.15%
2014-09-30 $5.94B $1.15B 19.36%
2014-06-30 $5.85B $1.15B 19.71%
2014-03-31 $5.80B $1.17B 20.16%
2013-12-31 $5.81B $1.22B 21.06%
2013-09-30 $5.78B $1.22B 21.17%
2013-06-30 $5.73B $1.22B 21.33%
2013-03-31 $5.69B $1.23B 21.61%
2012-12-31 $5.67B $1.26B 22.15%
2012-09-30 $5.63B $1.29B 22.86%
2012-06-30 $5.62B $1.28B 22.82%
2012-03-31 $5.60B $1.23B 22.05%
2011-12-31 $5.54B $1.18B 21.36%
2011-09-30 $5.47B $1.17B 21.40%
2011-06-30 $5.34B $1.16B 21.71%
2011-03-31 $5.18B $1.20B 23.12%
2010-12-31 $5.00B $1.19B 23.74%
2010-09-30 $4.87B $1.16B 23.84%
2010-06-30 $4.78B $1.16B 24.28%
2010-03-31 $4.73B $1.14B 23.98%
2009-12-31 $4.70B $1.14B 24.28%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.830B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
West Pharmaceutical Services (WST) United States $24.159B 43.30
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00